Oxidatively modified low-density lipoproteins (ox-LDL) have been strongly implicated in the pathogenesis of atherosclerosis. Both in vivo and in vitro experiments have shown that antioxidant treatment can attenuate oxidative damage from LDL. The aim of this study was to establish whether the ox-LDL
Inhibition of low density lipoprotein oxidation by melatonin
β Scribed by N. K. Zenkov; M. I. Dushkin; E. B. Men'shikova; Yu. I. Ragino; E. N. Pivovarova
- Publisher
- Springer US
- Year
- 1996
- Tongue
- English
- Weight
- 252 KB
- Volume
- 122
- Category
- Article
- ISSN
- 0007-4888
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Therapeutic strategies to increase high-density lipoprotein (HDL) to treat or prevent vascular disease include the use of cholesteryl-ester transfer protein (CETP) inhibitors. Here, we show, to the best of our knowledge for the first time, that addition of CETP to HDL enhances the ability of HDL to
## Abstract The role of OxLDL in the generation and progression of atherosclerosis is well admitted. In addition, it is well known that atherosclerosis is often accompanied by perturbations in bone remodeling, resulting in osteoporosis. In the current studies, the effect of Cu^2+^βoxidized LDL (OxL